Back to Journals » Drug Design, Development and Therapy » Volume 5

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Total article views   HTML views PDF downloads Totals
44,092 Dovepress* 21,329+ 3,690 25,019
PubMed Central* 22,763 3,811 26,574
Totals 44,092 7,501 51,593
*Since 10 March 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar